_id
6919e2ff3c536f8df2317ffa
Ticker
0RUG.LSE
Name
bioMerieux S.A.
Exchange
LSE
Address
376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280
Country
UK
Sector
Industry
Currency
EUR
Website
https://www.biomerieux.com
Description
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture media; BIOMERIEUX EPISEQ CS, a whole genome sequencing solution for epidemiologic monitoring; VIDAS, a specific marker of severe bacterial infections/sepsis; and Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making. It also provides culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration of an antibiotic; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. The company was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Last Close
105.36541
Volume
3805
Current Price
112.0075
Change
-0.9162494598559352
Last Updated
2025-12-05T15:15:09.571Z
Image
https://logo.clearbit.com/www.biomerieux.com
Ipo Date
-
Market Cap
12303650000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
50100000
Shares Outstanding
0
Income Tax Expense
34800000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
888900000
Inventories
840900000
Total Current Assets
2152700000
Property Plant Equipment
1392000000
Total Assets
-
Payables
243500000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
980700000
Equity
-
Depreciation
51500000
Change In Working Capital
-
Cash From Operations
73950000
Capital Expenditures
75150000
Cash From Investing
-73400000
Cash From Financing
-53050000
Net Change In Cash
-64000000
PE
-
PB
-
ROE
-
ROA
-
FCF
-1200000
Fcf Percent
-
Piotroski FScore
1
Health Score
46
Deep Value Investing Score
0.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2.5
Net Net Investing Score
0
Quality Investing Score
0.5
Value Investing Score
2
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
50100000
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
34800000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
888900000
Quarters > 0 > balance Sheet > inventories
840900000
Quarters > 0 > balance Sheet > total Current Assets
2152700000
Quarters > 0 > balance Sheet > property Plant Equipment
1392000000
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
243500000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
980700000
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > cash Flow > net Income
80800000
Quarters > 0 > cash Flow > depreciation
51500000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
73950000
Quarters > 0 > cash Flow > capital Expenditures
75150000
Quarters > 0 > cash Flow > cash From Investing
-73400000
Quarters > 0 > cash Flow > cash From Financing
-53050000
Quarters > 0 > cash Flow > net Change In Cash
-64000000
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-1200000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
50100000
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
34800000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
888900000
Quarters > 1 > balance Sheet > inventories
840900000
Quarters > 1 > balance Sheet > total Current Assets
2152700000
Quarters > 1 > balance Sheet > property Plant Equipment
1392000000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
243500000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
980700000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > cash Flow > net Income
80800000
Quarters > 1 > cash Flow > depreciation
51500000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
73950000
Quarters > 1 > cash Flow > capital Expenditures
75150000
Quarters > 1 > cash Flow > cash From Investing
-73400000
Quarters > 1 > cash Flow > cash From Financing
-53050000
Quarters > 1 > cash Flow > net Change In Cash
-64000000
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-1200000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
50100000
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
37450000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
926900000
Quarters > 2 > balance Sheet > inventories
737200000
Quarters > 2 > balance Sheet > total Current Assets
2216700000
Quarters > 2 > balance Sheet > property Plant Equipment
1369900000
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
269400000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1131100000
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > cash Flow > net Income
112200000
Quarters > 2 > cash Flow > depreciation
88300000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
162100000
Quarters > 2 > cash Flow > capital Expenditures
66950000
Quarters > 2 > cash Flow > cash From Investing
-87900000
Quarters > 2 > cash Flow > cash From Financing
-58200000
Quarters > 2 > cash Flow > net Change In Cash
7650000
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
95150000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
50100000
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
37450000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
926900000
Quarters > 3 > balance Sheet > inventories
737200000
Quarters > 3 > balance Sheet > total Current Assets
2216700000
Quarters > 3 > balance Sheet > property Plant Equipment
1369900000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
269400000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1131100000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > cash Flow > net Income
112200000
Quarters > 3 > cash Flow > depreciation
88300000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
162100000
Quarters > 3 > cash Flow > capital Expenditures
66950000
Quarters > 3 > cash Flow > cash From Investing
-87900000
Quarters > 3 > cash Flow > cash From Financing
-58200000
Quarters > 3 > cash Flow > net Change In Cash
7650000
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
95150000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
46
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
101200000
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
140100000
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
926900000
Annuals > 0 > balance Sheet > inventories
737200000
Annuals > 0 > balance Sheet > total Current Assets
2216700000
Annuals > 0 > balance Sheet > property Plant Equipment
1369900000
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
269400000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1131100000
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > cash Flow > net Income
452400000
Annuals > 0 > cash Flow > depreciation
277000000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
475100000
Annuals > 0 > cash Flow > capital Expenditures
286700000
Annuals > 0 > cash Flow > cash From Investing
-528100000
Annuals > 0 > cash Flow > cash From Financing
-244200000
Annuals > 0 > cash Flow > net Change In Cash
-258600000
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
188400000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
46
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-
Annuals > 1 > income Statement > net Income
-
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
73100000
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
175600000
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
701400000
Annuals > 1 > balance Sheet > inventories
634600000
Annuals > 1 > balance Sheet > total Current Assets
2207100000
Annuals > 1 > balance Sheet > property Plant Equipment
1224800000
Annuals > 1 > balance Sheet > total Assets
-
Annuals > 1 > balance Sheet > payables
239500000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
955800000
Annuals > 1 > balance Sheet > equity
-
Annuals > 1 > cash Flow > net Income
601100000
Annuals > 1 > cash Flow > depreciation
230900000
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
811100000
Annuals > 1 > cash Flow > capital Expenditures
290100000
Annuals > 1 > cash Flow > cash From Investing
-307300000
Annuals > 1 > cash Flow > cash From Financing
-127000000
Annuals > 1 > cash Flow > net Change In Cash
416000000
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-
Annuals > 1 > ratios > ROA
-
Annuals > 1 > ratios > FCF
521000000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
46
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
3118200000
Annuals > 2 > income Statement > cost Of Revenue
1364500000
Annuals > 2 > income Statement > gross Profit
1753700000
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
552200000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
524300000
Annuals > 2 > income Statement > net Income
404300000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
22500000
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
121500000
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
17.708934641780512
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > balance Sheet > cash
75700000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
682100000
Annuals > 2 > balance Sheet > inventories
541900000
Annuals > 2 > balance Sheet > total Current Assets
1661500000
Annuals > 2 > balance Sheet > property Plant Equipment
1068600000
Annuals > 2 > balance Sheet > total Assets
3927800000
Annuals > 2 > balance Sheet > payables
207100000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
352400000
Annuals > 2 > balance Sheet > total Liabilities
1496700000
Annuals > 2 > balance Sheet > equity
2431100000
Annuals > 2 > cash Flow > net Income
404400000
Annuals > 2 > cash Flow > depreciation
208800000
Annuals > 2 > cash Flow > change In Working Capital
-189700000
Annuals > 2 > cash Flow > cash From Operations
582800000
Annuals > 2 > cash Flow > capital Expenditures
277500000
Annuals > 2 > cash Flow > cash From Investing
-265200000
Annuals > 2 > cash Flow > cash From Financing
-176200000
Annuals > 2 > cash Flow > net Change In Cash
107300000
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
16.63033194850068
Annuals > 2 > ratios > ROA
10.293293955904069
Annuals > 2 > ratios > FCF
305300000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.09790905009300237
Annuals > 2 > health Score
65
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
2674800000
Annuals > 3 > income Statement > cost Of Revenue
1208200000
Annuals > 3 > income Statement > gross Profit
1466600000
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
370700000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
347600000
Annuals > 3 > income Statement > net Income
272900000
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
41300000
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
77800000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
13.85898011066248
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > balance Sheet > cash
34000000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
639900000
Annuals > 3 > balance Sheet > inventories
494700000
Annuals > 3 > balance Sheet > total Current Assets
1438500000
Annuals > 3 > balance Sheet > property Plant Equipment
1025200000
Annuals > 3 > balance Sheet > total Assets
3781900000
Annuals > 3 > balance Sheet > payables
211900000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
153700000
Annuals > 3 > balance Sheet > total Liabilities
1578000000
Annuals > 3 > balance Sheet > equity
2203900000
Annuals > 3 > cash Flow > net Income
272800000
Annuals > 3 > cash Flow > depreciation
187000000
Annuals > 3 > cash Flow > change In Working Capital
-96800000
Annuals > 3 > cash Flow > cash From Operations
407900000
Annuals > 3 > cash Flow > capital Expenditures
272500000
Annuals > 3 > cash Flow > cash From Investing
-282200000
Annuals > 3 > cash Flow > cash From Financing
-133900000
Annuals > 3 > cash Flow > net Change In Cash
-14300000
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
12.382594491583102
Annuals > 3 > ratios > ROA
7.21594965493535
Annuals > 3 > ratios > FCF
135400000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.050620607148197994
Annuals > 3 > health Score
55
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.840657084188912
Liquidity > metrics > Quick Ratio
5.387268993839836
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:59:15.200Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-27
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture media; BIOMERIEUX EPISEQ CS, a whole genome sequencing solution for epidemiologic monitoring; VIDAS, a specific marker of severe bacterial infections/sepsis; and Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making. It also provides culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration of an antibiotic; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. The company was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-06-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of bioMerieux S.A.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2023-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.